CF PHARMTECH (02652) spent HK$368,900 to repurchase 11,000 shares on January 2nd.
Changfeng Pharmaceuticals (02652) announced that on January 2, 2026, the company spent 368,900 Hong Kong dollars to repurchase 11,000 shares at a repurchase price of 33.34-34.00 Hong Kong dollars per share.
CF PHARMTECH (02652) announced on January 2, 2026 that the company will spend 368,900 Hong Kong dollars to repurchase 11,000 shares at a repurchase price of 33.34-34.00 Hong Kong dollars per share.
Related Articles
US Stock Market Move | Kunlun Core has secretly gone to Hong Kong for an IPO Baidu Inc Sponsored ADR Class A (BIDU.US) soared more than 10% before the market opened.
QYUNS-B(02509) spent HK$47.69 million on January 2nd to repurchase 25,000 shares.
Suzhou Novosense Microelectronics (02676): Partial Exercise of Oversubscription Rights, Price Stabilization Action and End of Price Stabilization Period
US Stock Market Move | Kunlun Core has secretly gone to Hong Kong for an IPO Baidu Inc Sponsored ADR Class A (BIDU.US) soared more than 10% before the market opened.
QYUNS-B(02509) spent HK$47.69 million on January 2nd to repurchase 25,000 shares.
Suzhou Novosense Microelectronics (02676): Partial Exercise of Oversubscription Rights, Price Stabilization Action and End of Price Stabilization Period
